Overview SSRI and Buprenorphine Status: Completed Trial end date: 2009-09-01 Target enrollment: Participant gender: Summary This study is designed to test whether treatment of depressive symptoms using escitalopram improves adherence to Buprenorphine and reduces symptoms of depression for individuals receiving Buprenorphine through their medical provider. Phase: Phase 3 Details Lead Sponsor: Butler HospitalTreatments: BuprenorphineCitalopramDexetimide